VALIDATION OF LIVERFAST- GP plus ( GP plus ) AS A NONINVASIVE TEST FOR RISK STRATIFICATION FOR PATIENTS WITH NON- ALCOHOLIC FATTY LIVER DISEASE ( NAFLD): SINGLECENTRE STUDY USING LIVER BIOPSY AS REFERENCE STANDARD.
HEPATOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined